Evidence map›Paper›PMID 37899246›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Clostridium paraputrificum Bacteremia in a Patient with Rectal Cancer after Receiving Antibiotic Therapy for Acute Pharyngolaryngitis.

Yasunori Maeda, Ryo Miura, Takuma Echizenya, Kentaro Hoshi, Norihito Kubo, Hajime Nakai, Kazuhito Matsumoto, Shin Ikejima, Naomi Kudo, Atsushi Matsubara

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yasunori MaedaDepartment of Otorhinolaryngology, Odate Municipal General Hospital, Japan.
Ryo MiuraDepartment of Otorhinolaryngology, Odate Municipal General Hospital, Japan.
Takuma EchizenyaDepartment of Clinical Laboratory, Odate Municipal General Hospital, Japan.
Kentaro HoshiDepartment of Gastroenterology-Hematology-Oncology, Odate Municipal General Hospital, Japan.
Norihito KuboDepartment of Surgery, Odate Municipal General Hospital, Japan.
Hajime NakaiDepartment of Pharmacy, Odate Municipal General Hospital, Japan.
Kazuhito MatsumotoDepartment of Pathology, Odate Municipal General Hospital, Japan.
Shin IkejimaDepartment of Endocrinology-Metabolism-Neurology, Odate Municipal General Hospital, Japan.
Naomi KudoDepartment of Otorhinolaryngology-Head and Neck Surgery, Hirosaki University Graduate School of Medicine, Japan.
Atsushi MatsubaraDepartment of Otorhinolaryngology-Head and Neck Surgery, Hirosaki University Graduate School of Medicine, Japan.
Ome Municipal General Hospital · JPHirosaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridium paraputrificum bacteremia is very rare, and its clinical importance is poorly understood. An 86-year-old man was receiving lascufloxacin therapy for acute pharyngolaryngitis before presenting to our emergency department with a recurrent fever. Two sets of blood cultures on admission revealed C. paraputrificum. A stool culture showed a reduced presence of intestinal commensal bacteria. After admission, the patient's fever resolved without antibiotics. Colonoscopy revealed a rectal tumor. Rectal tumor and microbial substitutions caused by antibiotics may have led to bacteremia. When treating C. paraputrificum bacteremia, physicians should be mindful of coexisting gastrointestinal disorders and a history of antibiotic administration.

Indexed as

Anti-Bacterial AgentsBacteremiaClostridium InfectionsRectal NeoplasmsAcute DiseaseAged, 80 and overClostridiumHumansLaryngitisMalePharyngitisAnti-Bacterial AgentsbacteremiaClostridioides difficile infectionClostridium paraputrificumlascufloxacinmicrobial substitutionrectal cancer

Identifiers

PMID37899246
PMCPMC11189701
OpenAlexW4388014711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.